IQVIA’s Regulatory Science Series
Showcasing innovative approaches to evidence generation for regulatory decision making
Staying on top of emerging science and technology, and the regulatory frameworks within which to utilize innovations in the regulated space, can be challenging. That’s why we’ve launched the Regulatory Science Series.
By featuring a range of topics that are key to the modernization of evidence generation for regulated products, we seek to expand the conversation around evolving regulatory landscapes. Complex and dynamic areas of interest include, but are not limited to, real world data (RWD) and real world evidence (RWE), clinical trial design, digital health technologies, drug safety, and post-market surveillance.
If you would like to continue the conversation with an IQVIA expert, please complete the form below.
